Medical and Pharmaceutical Industry - Market Research Report

San Francisco, 25 September 2025, –  The global   immunoassay analyzers market   size is anticipated to reach USD 9,150.4 million by 2030 and is expected to expand at a CAGR of 4.1% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic and infectious diseases drives the market, intensifying the demand for accurate and timely diagnostic solutions. As conditions such as cancer, cardiovascular disorders, and autoimmune diseases become more widespread, healthcare providers are increasingly relying on immunoassay technologies for early detection, disease monitoring, and treatment planning. These analyzers offer high sensitivity and specificity, making them indispensable tools in clinical laboratories and hospital settings. Technological advancements are also pivotal in market expansion. Innovations in chemiluminescence, fluorescence, and enzyme-linked immunoassay platforms have significantly improved throughput, aut...

In 2023, the global   plaque modification and removal devices market   was valued at approximately USD 1.86 billion, and it is forecast to reach around USD 3.26 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.4% between 2024 and 2030. The driving forces behind this growth include a rising incidence of cardiovascular diseases globally, especially atherosclerosis; an ageing population; greater health care spending; improvements in diagnostic technologies; and growing awareness of preventive cardiovascular care. Increasing cases of hypertension, lifestyle-related risk factors, and smoking also contribute to plaque accumulation in arteries, which raises the demand for more effective treatment methods. Key Market Trends & Insights and Market Size & Forecast Regionally, North America led the market in 2023, holding a revenue share of about 43.69%. The Asia-Pacific region is expected to grow the fastest over the forecast period, with a CAGR of approxim...